Neuberger Berman Group LLC Enzo Biochem Inc Transaction History

Neuberger Berman Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.17 - $4.09 $34,350 - $44,319	-10,836 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.01 - $3.77 $32,616 - $40,851	10,836 New	10,836 $38,000
Q4 2020 Feb 10, 2021	SELL	$1.82 - $2.61 $40,646 - $58,289	-22,333 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$3.01 - $4.0 $842 - $1,120	-280 Reduced 1.24%	22,333 $80,000
Q1 2018 May 08, 2018	SELL	$5.43 - $8.36 $2,720 - $4,188	-501 Reduced 2.17%	22,613 $124,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $6,365 - $8,239	-781 Reduced 3.27%	23,114 $188,000
Q3 2017 Nov 15, 2017	BUY	$10.45 - $11.44 $249,702 - $273,358	23,895	23,895 $250,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $51.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.